The adult intraventricular hemorrhage global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Adult Intraventricular Hemorrhage Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The adult intraventricular hemorrhage market size has grown strongly in recent years. It will grow from $1.97 billion in 2023 to $2.09 billion in 2024 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to advancements in neuroimaging techniques, an increase in hypertension and cardiovascular diseases, the growing elderly population, an increase in incidents of traumatic brain injuries, and medical technology innovations.
The adult intraventricular hemorrhage market size is expected to see strong growth in the next few years. It will grow to $2.66 billion in 2028 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to innovations in minimally invasive surgical techniques, enhanced healthcare infrastructure, increased focus on stroke prevention and management, development of new pharmacological treatments, and growing awareness and education programs. Major trends in the forecast period include the rise of telemedicine and remote monitoring, the development of targeted therapies, the expansion of comprehensive stroke centers, enhanced rehabilitation services, and a trend toward personalized medicine.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/adult-intraventricular-hemorrhage-global-market-report
Scope Of Adult Intraventricular Hemorrhage Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Adult Intraventricular Hemorrhage Market Overview
Market Drivers –
The increasing incidence of strokes is expected to propel the growth of the adult intraventricular hemorrhage market going forward. A stroke is a medical emergency that occurs when blood flow to the brain is interrupted or reduced, leading to brain cell damage. The increasing incidence of strokes is primarily due to factors such as an aging population, rising rates of hypertension, diabetes, and obesity, and lifestyle-related risk factors such as smoking and physical inactivity. Strokes can cause adult intraventricular hemorrhage (IVH) by leading to bleeding within the brain’s ventricular system, often due to ruptured blood vessels. For instance, in June 2024, according to the Australian Bureau of Statistics, an Australia-based government agency, there were 9,100 doctor-certified deaths due to cerebrovascular diseases, including stroke, in 2020. This number rose to 9,300 in both 2021 and 2022. This increase marks a reversal of a historical decline, with the number of deaths in 2022 being 2.2% higher than in 2020. Therefore, the increasing incidence of strokes is driving the growth of the adult intraventricular hemorrhage market.
Market Trends –
Major companies operating in the adult intraventricular hemorrhage market are focused on developing innovative products, such as neuroaccess devices, for neurovascular management of ischemic and hemorrhagic strokes. Neuroaccess devices are medical tools used to gain entry to the brain or spinal cord for diagnostic or therapeutic procedures. For instance, in June 2024, Penumbra Inc., a US-based medical device company, announced the CE Mark approval and European launch of its BMX81 and BMX96 neuroaccess devices for managing ischemic and hemorrhagic stroke. These devices are designed for the neurovascular management of ischemic and hemorrhagic strokes and are Penumbra’s most advanced neuroaccess offerings. Unlike traditional access catheters, the BMX81 and BMX96 are made using laser-cut stainless steel hypo tube technology, offering stability and trackability to allow physicians to easily navigate the brain’s complex anatomy.
The adult intraventricular haemorrhage market covered in this report is segmented –
1) By Product Type: Surgical Devices, Drugs, Monitoring Devices
2) By Distribution Channel: Direct Sales, Distributors, Online Platforms, Other Distribution Channels
3) By Application: Intraventricular Hemorrhage, Intracerebral Hemorrhage, Subarachnoid Hemorrhage, Other Applications
4) By End-User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Diagnostic Centers, Other End-Users
Get an inside scoop of the adult intraventricular hemorrhage market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=17051&type=smp
Regional Insights –
North America was the largest region in the adult intraventricular hemorrhage market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adult intraventricular haemorrhage market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies –
Major companies operating in the adult intraventricular haemorrhage market are Johnson and Johnson, Abbott Laboratories, Medtronic Plc, Siemens Healthineers, Medline Industries, Philips Healthcare Inc., Stryker Corporation, GE HealthCare Technologies Inc., Teva Pharmaceutical Industries Ltd., Boston Scientific Corporation, B. Braun Melsungen AG, Alcon Inc., Zimmer Biomet Holdings Inc., Olympus Corporation, Smith and Nephew, Kaneka Corporation, Karl Storz SE and Co. KG, Carl Zeiss Meditec AG, Integra Lifesciences Holdings Corp, Elekta AB, Leica Microsystems GmbH, KLS Martin Group, Natus Medical Incorporated, Aesculap Inc., NeuroPace Inc., Sophysa USA Inc, Spiegelberg GmbH and Co. KG, Vivonics Inc.
Table of Contents
1. Executive Summary
2. Adult Intraventricular Hemorrhage Market Report Structure
3. Adult Intraventricular Hemorrhage Market Trends And Strategies
4. Adult Intraventricular Hemorrhage Market – Macro Economic Scenario
5. Adult Intraventricular Hemorrhage Market Size And Growth
…..
27. Adult Intraventricular Hemorrhage Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
